The Arizona Alzheimer's Consortium (AAC), established in 1998, is the nation's leading statewide collaboration in Alzheimer's disease research. The Consortium unites its participating institutions' strengths in brain imaging, computer science, genomics, basic and cognitive neurosciences as well as clinical and neuropathology research to promote the scientific understanding and early detection of Alzheimer's disease in addition to finding effective disease-stopping and prevention therapies.
“The Alzheimer's Association is a valuable partner with the Arizona Alzheimer’s Consortium,” said David Jerman, the AAC’s Administrative Director. “The work they do in our community is vital to the health and well being of those individuals and families affected by Alzheimer’s.”
The Arizona Alzheimer's Consortium includes the state-supported Arizona Alzheimer's Research Center, the National Institute on Aging, the Arizona Disease Core Center and independently funded research programs.
Its seven member institutions include: Arizona State University, Banner Alzheimer's Institute, Banner Sun Health Research Institute, Barrow Neurological Institute, Mayo Clinic Arizona, the Translational Genomics Research Institute (TGen) and the University of Arizona.
Its three affiliated institutions include Banner Good Samaritan Medical Center, the Southern Arizona Veterans Administration Health Care System and the University Physician's Hospital at Kino.
This collaborative team of leading medical and scientific experts shares one over-riding goal: finding demonstrably effective treatments to stop and end Alzheimer’s disease as soon as possible.
“The Arizona Alzheimer’s Consortium is an exemplary model of institutions working together for the common good,” said Dan Lawler, Alzheimer's Association Desert Southwest Development Director. “We are proud of our partnership, as together we work towards a world without Alzheimer’s disease.”